Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125799871 | 12579987 | 1 | I | 20160103 | 20160714 | 20160721 | 20160721 | EXP | DE-AMGEN-DEUSP2016092065 | AMGEN | 0.00 | F | Y | 0.00000 | 20160721 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125799871 | 12579987 | 1 | PS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 TIMES IN 2 WEEKS | 125031 | 6 | MG | UNKNOWN FORMULATION | |||||||
| 125799871 | 12579987 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Oral | 630 MG, 1 TIMES IN 2 WEEK(S) | 0 | 630 | MG | ||||||||
| 125799871 | 12579987 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1300 MG, 1 TIME IN 2 WEEKS | 0 | 1300 | MG | ||||||||
| 125799871 | 12579987 | 4 | SS | DOXORUBICINE /00330901/ | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 87 MG, 1 TIMS IN 2 WEEKS | 0 | 87 | MG | ||||||||
| 125799871 | 12579987 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 3.5 MG, 1 TIMES IN 2 WEEKS | 0 | 3.5 | MG | ||||||||
| 125799871 | 12579987 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, D 1-5 IN 14 DAYS | 0 | 100 | MG | ||||||||
| 125799871 | 12579987 | 7 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD (1 TIMES A DAY (S)) | 0 | 40 | MG | QD | |||||||
| 125799871 | 12579987 | 8 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 2.5 MG, (1 TIMES A DAY (S)) | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125799871 | 12579987 | 1 | B-cell lymphoma |
| 125799871 | 12579987 | 2 | B-cell lymphoma |
| 125799871 | 12579987 | 3 | B-cell lymphoma |
| 125799871 | 12579987 | 4 | B-cell lymphoma |
| 125799871 | 12579987 | 5 | B-cell lymphoma |
| 125799871 | 12579987 | 6 | B-cell lymphoma |
| 125799871 | 12579987 | 7 | Prophylaxis |
| 125799871 | 12579987 | 8 | Cardiac failure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125799871 | 12579987 | HO |
| 125799871 | 12579987 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125799871 | 12579987 | Pneumonia aspiration | |
| 125799871 | 12579987 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125799871 | 12579987 | 1 | 20150409 | 20150629 | 0 | |
| 125799871 | 12579987 | 2 | 20150407 | 20151210 | 0 | |
| 125799871 | 12579987 | 3 | 20150409 | 20150624 | 0 | |
| 125799871 | 12579987 | 4 | 20150409 | 20150624 | 0 | |
| 125799871 | 12579987 | 5 | 20150409 | 20150507 | 0 | |
| 125799871 | 12579987 | 6 | 20150407 | 20150628 | 0 |